163Additional requirements for supplying controlled

163 Additional requirements for supplying controlled medicines for human use during consultations The following are the additional requirements for supplying a controlled medicine for human use during a consultation: (a) the prescriber has a controlled medicines approval to prescribe Note For controlled medicines approvals, see pt 13.1. (b) if the approval is for a particular form of the medicine—the supply is for the form of the medicine approved or a bioequivalent form;

Supplying medicines during consultations Division 4.2.6 (c) if the approval is for a particular strength of the medicine—the supply is for the strength approved or a weaker strength; (d) if the approval is for a maximum daily dose of the medicine— the supply is for not more than the maximum daily dose approved; (e) the prescriber complies with each condition (if any) of the approval. If a slow release form of a medicine is approved, the prescriber is not authorised to prescribe an immediate release form of the medicine.